The impact of repeated cycles of radioligand therapy using [177Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancer.
Eur J Nucl Med Mol Imaging
; 44(9): 1473-1479, 2017 Aug.
Article
in En
| MEDLINE
| ID: mdl-28337529
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Radioisotopes
/
Dipeptides
/
Heterocyclic Compounds, 1-Ring
/
Hormones
/
Kidney
/
Lutetium
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Humans
/
Male
Language:
En
Year:
2017
Type:
Article